[ Price : $8.95]
FDA grants GT Biologics an orphan drug designation for Thetanix (bacteroides thetaiotaomicron) for treating pediatric Crohns disea...[ Price : $8.95]
FDA and Cell Therapeutics reach agreement on a Special Protocol Assessment for a planned pivotal Phase 3 clinical trial known as t...[ Price : $8.95]
CEL-SCI Corp. signs a research agreement with the U.S. Naval Medical Center in San Diego to conduct a Phase 1 study of Multikine i...[ Price : $8.95]
FDA approves a Baxter healthcare NDA for Clinolipid (lipid injectable emulsion, USP) for intravenous feeding (parenteral nutrition...[ Price : $8.95]
Roche and Genentech begin a Phase 1b/2 study of Erivedge in patients with relapsed/ refractory acute myelogenous leukemia and rela...[ Price : $8.95]
FDA approves Discovery Laboratories updated product specifications for Surfaxin (lucinactant) Intratracheal Suspension, indicated ...[ Price : $8.95]
FDA appears to be supporting approval of a CardioMEMS PMA for its Champion HF Monitoring System, an implantable pressure measureme...[ Price : $8.95]
FDA says the ongoing budget impasse and partial government shutdown should not affect its routine product review process for drug ...